Modern Healthcare (Gold)

What’s a New Cancer Drug Worth?
Merrill Goozner

Judging comments:
“Carefully walks reader through indefensible pricing policies of drugs allowed onto the market but not yet fully tested. Skillfully crafted argument that prepares reader for well-reasoned conclusion. All this despite the complexity of the topic.